Advertisement

Cytostatic and Antitumour Properties for a New Series of Pt(II) Complexes with Cyclopentylamine

  • V. Scarcia
  • A. Furlani
  • A. Papaioannou
  • D. G. Craciunescu
  • A. Doadrio
Part of the Developments in Oncology book series (DION, volume 54)

Abstract

It is well-known that the alicyclic amine derivatives of cisplatin are less toxic as the ring size increases from cyclo-propylamine to cyclohexylamine, whereas the antitumour activity remains largely unalterated (1). Nevertheless the cyclopentylamine complex shows a larger spectrum of activity than the cyclohexylamine analog.

Keywords

Anti Tumour Activity Antitumour Activity Propyl Amine Anti Tumour Cytostatic Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Connors T.A., Jones M., Ross W.C.J., Braddock P.D., Khokhar A.R. and Tobe M.L., Chem.-Biol. Interact., 5: 415, 1972.PubMedCrossRefGoogle Scholar
  2. 2.
    Cleare M.J., Hydes P.C., Hepburn D.R. and Malerbi B.W. In: Cis-platin. Current status and new developments. (Prestayko A.W., Crooke S.T. and Carter S.K. eds.), New York, Academic Press, 1980, pp. 149.Google Scholar
  3. 3.
    Craciunescu D.G., Scarcia V., Furlani Candiani A., Doadrio A., Ghirvu C. and Ravalico L., J.Pharm.Belg., 41: 286, 1986.PubMedGoogle Scholar
  4. 4.
    Geran R.I., Greenberg N.H., MacDonald M.M., Schumacher A.M. and Abbott B.J., Cancer Chemother.Rep., 3:1, 1972.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1988

Authors and Affiliations

  • V. Scarcia
  • A. Furlani
  • A. Papaioannou
  • D. G. Craciunescu
  • A. Doadrio

There are no affiliations available

Personalised recommendations